Ligand · KGY
KGY · 4-({[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}methyl)-1-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-N-hydroxypiperidine-4-carboxamide
KGY, 4-({[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}methyl)-1-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-N-hydroxypiperidine-4-carboxamide (C22 H27 N3 O8 S2, 525.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- KGY
- Formula
- C22 H27 N3 O8 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
KGY in 2 structures; the first of them:
- 2I47 · Crystal structure of catalytic domain of TACE with inhibitor · KGY C1001 · binds VAL314, LYS315, GLY346, THR347, LEU348, GLY349, LEU350, GLU398 and 12 more
- 2I47 · Crystal structure of catalytic domain of tace with inhibitor · KGY C1001 · binds VAL314, LYS315, GLY346, THR347, LEU348, GLY349, LEU350, GLU398 and 12 more
Residues it binds most
VAL 4, HIS 4, LEU 4, GLU 4, GLY 4, ALA 4, ILE 4, LYS 4, PRO 4, THR 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.